Opioids Market (By Product: IR/Short-Acting Opioids, ER/Long-Acting Opioids; By Application: Pain Relief, Anesthesia, Cough Suppression, Diarrhea Suppression, De-addiction; By Route of Administration: Oral, Injectable, Others; By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Opioids Market 

5.1. COVID-19 Landscape: Opioids Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Opioids Market, By Product

8.1. Opioids Market Revenue and Volume Forecast, by Product, 2023-2032

8.1.1. IR/Short-Acting Opioids

8.1.1.1. Market Revenue and Volume Forecast (2020-2032)

8.1.2. ER/Long-Acting Opioids

8.1.2.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 9. Global Opioids Market, By Application

9.1. Opioids Market Revenue and Volume Forecast, by Application, 2023-2032

9.1.1. Pain Relief

9.1.1.1. Market Revenue and Volume Forecast (2020-2032)

9.1.2. Anesthesia

9.1.2.1. Market Revenue and Volume Forecast (2020-2032)

9.1.3. Cough Suppression

9.1.3.1. Market Revenue and Volume Forecast (2020-2032)

9.1.4. Diarrhea Suppression

9.1.4.1. Market Revenue and Volume Forecast (2020-2032)

9.1.5. De-addiction

9.1.5.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 10. Global Opioids Market, By Route of Administration 

10.1. Opioids Market Revenue and Volume Forecast, by Route of Administration, 2023-2032

10.1.1. Oral

10.1.1.1. Market Revenue and Volume Forecast (2020-2032)

10.1.2. Injectable

10.1.2.1. Market Revenue and Volume Forecast (2020-2032)

10.1.3. Others

10.1.3.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 11. Global Opioids Market, By Distribution Channel 

11.1. Opioids Market Revenue and Volume Forecast, by Distribution Channel, 2023-2032

11.1.1. Hospital Pharmacy

11.1.1.1. Market Revenue and Volume Forecast (2020-2032)

11.1.2. Retail Pharmacy

11.1.2.1. Market Revenue and Volume Forecast (2020-2032)

11.1.3. Others

11.1.3.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 12. Global Opioids Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.1.2. Market Revenue and Volume Forecast, by Application (2020-2032)

12.1.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.1.4. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.1.5.2. Market Revenue and Volume Forecast, by Application (2020-2032)

12.1.5.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.1.5.4. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.1.6.2. Market Revenue and Volume Forecast, by Application (2020-2032)

12.1.6.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.1.6.4. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.2.2. Market Revenue and Volume Forecast, by Application (2020-2032)

12.2.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.2.4. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.2.5.2. Market Revenue and Volume Forecast, by Application (2020-2032)

12.2.5.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.2.5.4. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.2.6.2. Market Revenue and Volume Forecast, by Application (2020-2032)

12.2.6.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.2.6.4. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.2.7.2. Market Revenue and Volume Forecast, by Application (2020-2032)

12.2.7.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.2.7.4. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.2.8.2. Market Revenue and Volume Forecast, by Application (2020-2032)

12.2.8.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.2.8.4. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.3.2. Market Revenue and Volume Forecast, by Application (2020-2032)

12.3.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.3.4. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.3.5.2. Market Revenue and Volume Forecast, by Application (2020-2032)

12.3.5.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.3.5.4. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.3.6.2. Market Revenue and Volume Forecast, by Application (2020-2032)

12.3.6.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.3.6.4. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.3.7.2. Market Revenue and Volume Forecast, by Application (2020-2032)

12.3.7.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.3.7.4. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.3.8.2. Market Revenue and Volume Forecast, by Application (2020-2032)

12.3.8.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.3.8.4. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.4.2. Market Revenue and Volume Forecast, by Application (2020-2032)

12.4.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.4.4. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.4.5.2. Market Revenue and Volume Forecast, by Application (2020-2032)

12.4.5.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.4.5.4. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.4.6.2. Market Revenue and Volume Forecast, by Application (2020-2032)

12.4.6.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.4.6.4. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.4.7.2. Market Revenue and Volume Forecast, by Application (2020-2032)

12.4.7.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.4.7.4. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.4.8.2. Market Revenue and Volume Forecast, by Application (2020-2032)

12.4.8.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.4.8.4. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.5.2. Market Revenue and Volume Forecast, by Application (2020-2032)

12.5.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.5.4. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.5.5.2. Market Revenue and Volume Forecast, by Application (2020-2032)

12.5.5.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.5.5.4. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.5.6.2. Market Revenue and Volume Forecast, by Application (2020-2032)

12.5.6.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.5.6.4. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

Chapter 13. Company Profiles

13.1. Mallinckrodt Pharmaceuticals LLC

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Purdue Pharmaceuticals L.P.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Sun Pharmaceutical Industries Ltd

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Teva Pharmaceuticals Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Vertice Pharma LLC

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Johnson and Johnson

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. AbbVie Inc (Allergan PLC)

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Hikma Pharmaceuticals PLC

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Endo Pharmaceuticals Inc.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Zyla Life Sciences (Egalet Corporation)

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

PROCEED TO BUY :

   USD 5400
   USD 3800
   USD 2100
   USD 2100
   USD 7500

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample